← BMJ Neurology Open

Papers in BMJ Neurology Open

Page 9 · newest first

401. Neurological implications of COVID-19: a review of the science and clinical guidanceBMJ Neurology Open · 2020
402. Alzheimer’s disease: from basic science to precision medicine approachSHILAP Revista de lepidopterología · 2020
403. Postural sway correlates with cognition and quality of life in Parkinson’s diseaseBMJ Neurology Open · 2020
404. Discovering themes in medical records of patients with psychogenic non-epileptic seizuresBMJ Neurology Open · 2020
405. Plegia to walking: AHSCBMT in severe NMOSD relapseBMJ Neurology Open · 2020
406. Impairments in path integration, rotational memory and balancing in patients with temporal lobe epilepsyBMJ Neurology Open · 2020
407. Potential biomarkers and challenges in glioma diagnosis, therapy and prognosisSHILAP Revista de lepidopterología · 2020
408. May lamotrigine be an alternative to topiramate in the prevention of migraine with aura? Results of a retrospective studyBMJ Neurology Open · 2020
409. COVID-19 exposes the urgent need for coding of outpatient neurology episodesBMJ Neurology Open · 2020
410. Individual vulnerabilities to psychosis after antiepileptic drug administrationBMJ Neurology Open · 2020
411. Burden of adult neurological diseases in Odeda Area, Southwest NigeriaBMJ Neurology Open · 2020
412. Association of cerebral blood flow with myelin content in cognitively unimpaired adultsBMJ Neurology Open · 2020
413. Safety and acceptability of clozapine and risperidone in progressive multiple sclerosis: a phase I, randomised, blinded, placebo-controlled trialBMJ Neurology Open · 2020
414. Functional neurological disorders: effective teaching for health professionalsSHILAP Revista de lepidopterología · 2020
415. Hospital diagnosed pneumonia before age 20 years and multiple sclerosis riskBMJ Neurology Open · 2020
416. Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicityBMJ Neurology Open · 2020
417. Real-life outcomes in spasticity management: features affecting goal achievementBMJ Neurology Open · 2020
418. Moyamoya vasculopathy in a young Caucasian woman with significant methamphetamine useBMJ Neurology Open · 2020
419. Impact of interhospital transfer on patients undergoing endovascular thrombectomy for acute ischaemic stroke in an Australian settingBMJ Neurology Open · 2020
420. Chronic inflammatory demyelinating polyradiculoneuropathy presenting as predominantly sciatic monomelic neuropathyBMJ Neurology Open · 2020
421. Variations in the patterns of prevalence and therapy in Australasian Parkinson’s disease patients of different ethnicitiesBMJ Neurology Open · 2020
422. Myasthenia gravis and concurrent myositis following PD-L1 checkpoint inhibitor for non-small cell lung cancerBMJ Neurology Open · 2020
423. Effect of remote ischaemic preconditioning on walking in people with multiple sclerosis: double-blind randomised controlled trialBMJ Neurology Open · 2020
424. Case report and literature review of Huntington disease with intermediate CAG expansionBMJ Neurology Open · 2020
425. When the fat hits the brain—salvage STA–MCA bypass for an intracranial ICA occlusion due to a fat embolusBMJ Neurology Open · 2020
426. Parkinsonism in the psychiatric setting: an update on clinical differentiation and managementBMJ Neurology Open · 2020
427. Cognitive effects of onabotulinumtoxinA in chronic migraineBMJ Neurology Open · 2020
428. Therapeutic plasma exchange (TPE) for semi-critical neurology presentations in a non-acute neurology set-up: clinical practice and challengesBMJ Neurology Open · 2020
429. Cerebrospinal fluid cannot be used to distinguish inflammatory myelitis from congestive myelopathy due to spinal dural arteriovenous fistula: case seriesBMJ Neurology Open · 2019
430. Progressive cranial neuropathy and uterine involvement in myeloid sarcomaBMJ Neurology Open · 2019